Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 534-538

  Chan, Ellis ^a   Charles, Perrine ^b   Ribai, Pascale ^b,c,d,e   Goizet, Cyril ^f   Marelli, Cecilia ^b,c,d,e   Vincitorio, Carlo Maria ^b   Bayon, Alice Le ^g   Guyant Maréchal, Lucie ^h   Vandenberghe, Nadia ⁱ   Anheim, Mathieu ^b   Devos, David ^j   Freeman, Leorah ^b   Ber, Isabelle Le ^b,c,d,e   N'Guyen, Karine ^k   Tchikviladzé, Maya ^b,c   Labauge, Pierre ^g   Hannequin, Didier ^h   Brice, Alexis ^b,c,d,e   Durr, Alexandra ^b,c,d,e   Du Montcel, Sophie Tezenas ^a,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e CNRS   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL NEUROLOGIQUE   (France)

^j UNIV LILLE   (France)

^k TIMONE HOSPITAL   (France)

more..

Author keywords

Clinical neurology examination; Gait disorder ataxia; Outcome research; Responsiveness; Spinocerebellar ataxia

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CEREBELLAR FUNCTIONAL SEVERITY SCORE; CEREBELLUM DISEASE; COMPOSITE CEREBELLAR FUNCTIONAL SEVERITY SCORE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EFFECT SIZE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SPINOCEREBELLAR ATAXIA TYPE 1; SPINOCEREBELLAR ATAXIA TYPE 2; SPINOCEREBELLAR ATAXIA TYPE 3; SPINOCEREBELLAR DEGENERATION;

EID: 79953277710     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23531     Document Type: Article

References (18)

1. Stevanin G, Durr A, Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 2000; 8: 4-18.
2. Fahey MC, Corben L, Collins V, Churchyard AJ, Delatycki MB. How is disease progress in Friedreich's ataxia best measured? A study of four rating scales. J Neurol Neurosurg Psychiatry 2007; 78: 411-413.
3. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997; 145: 205-211.
4. Subramony SH, May W, Lynch D, et al. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology 2005; 64: 1261-1262.
5. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006; 66: 1717-1720.
6. Schmitz-Hubsch T, Giunti P, Stephenson DA, et al. SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology 2008; 71: 486-492.
7. du Montcel ST, Charles P, Ribai P, et al. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain 2008; 131( Pt 5): 1352-1361.
8. Klockgether T, Ludtke R, Kramer B, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998; 121 ( Pt 4): 589-600.
9. Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. Practitioner 1964; 192: 540-542.
10. Kamath C, Sloan J, Cappelleri J. Clinical significance. In: D'Agostino RB, Sullivan L, Massaro J, editors. Wiley Encyclopedia of Clinical Trials. Hoboken, New Jersey: Wiley, 2008. p 306-324.
11. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press; 1977.
12. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 420-428.
13. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592.
14. Schmitz-Hubsch T, Fimmers R, Rakowicz M, et al. Responsiveness of different rating instruments in spinocerebellar ataxia patients. Neurology 2010; 74: 678-684.
15. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27( 3 Suppl): S178-S189.
16. Stucki G, Liang MH, Fossel AH, Katz JN. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 1995; 48: 1369-1378.
17. Geschwind DH, Perlman S, Figueroa KP, Karrim J, Baloh RW, Pulst SM. Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations. Neurology 1997; 49: 1247-1251.
18. David G, Durr A, Stevanin G, et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 1998; 7: 165-170.